Clinical advances in hematology

The American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, was held on the 9–12 December. ASH 2017 showcased cutting-edge updates in the clinical management of hematological malignancies.

The hot topics at this years' meeting included new CAR T-cell data, updates from exciting late-phase clinical trials, including MURANO and ALCYONE, and the use of NGS for standard diagnostics and MRD monitoring.

View all videos

ASH 2017

Annual Meeting and Exposition

09–12 December 2017 | Atlanta, GA

Clinical advances in hematology

The American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, was held on the 9–12 December. ASH 2017 showcased cutting-edge updates in the clinical management of hematological malignancies.

The hot topics at this years' meeting included new CAR T-cell data, updates from exciting late-phase clinical trials, including MURANO and ALCYONE, and the use of NGS for standard diagnostics and MRD monitoring.

View all videos

CLL updates from ASH 2017

Jacqueline Barrientos • 9 Dec 2017

MURANO trial: revolutionizing the standard of care for relapsed CLL patients

Stephan Stilgenbauer

Curative strategy for smoldering multiple myeloma: GEM-CESAR

Maria-Victoria Mateos • 9 Dec 2017

MRD-guided high-dose carfilzomib treatment for multiple myeloma

Ola Landgren • 9 Dec 2017

Update on immunotherapy trials for AML from ASH 2017: bispecific DARTs, CAR T-cells and ADCs

Marina Konopleva • 9 Dec 2017

AML highlights from ASH 2017

Charles Craddock • 9 Dec 2017

Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells

Nirali Shah • 9 Dec 2017

Treating lymphoma beyond progression

Graham Collins • 9 Dec 2017

Elderly ALL advances: inotuzumab ozogamicin plus mini-hyper-CVD

Susan O’Brien • 9 Dec 2017

Anti-CD22 CAR T-cell therapy for ALL: trial update, utility for salvage and CD19 status

Nirali Shah • 9 Dec 2017